GENFIT’s Post

📣 We’re advancing a diverse pipeline to tackle Acute-on-Chronic Liver Failure (#ACLF) — a serious but potentially reversible condition with high unmet need and no approved treatments. 👉 Learn more about ACLF at https://lnkd.in/eXWyRg37 #LiverDisease #Cirrhosis #RareDisease #OrganFailure #DrugDevelopment #Hepatology #MedicalResearch

Today, NEJM Group published detailed results from our RESPONSE Phase 3 trial evaluating the use of our investigational therapy in adults with primary biliary cholangitis (PBC). We look forward to the positive impact this research could have on patients and the medical community. Learn more here: bit.ly/3OT9oox   #PrimaryBiliaryCholangitis #PBC #LiverDisease #Hepatology

The ECL 412, a Coagulation Analyzer by Erba Transasia, has four testing positions, offering a compact and user-friendly solution. Its versatile functionality allows for testing a wide range of routine and special parameters including Clotting, Chromogenic and Immunoturbidimetry assays. Discover more on https://zurl.co/OKQL or reach out to us at 7304448818. #IAmTransasia #WeAreErba #coagulation #hemostasis #analyzer #thrombosis #bleedingdisorders #PT #APTT #Ddimer #fibrinogen #IVD #pathology #clinicalanalysis #laboratorymedicine

Great achievement by the Dutch Mesenteric Ischemia Study Group. Covered stenting is the preferred treatment for patients undergoing mesenteric artery stenting for chronic mesenteric ischemia. Honored to have been part of this double-blind randomized trial which is now published in the Lancet Gastroenterology and Hepatology. Another good example of Dutch scientific collaboration to overcome vascular pathologies. Big applause to Luke Terlouw and Louisa van Dijk and the entire DMIS group. https://lnkd.in/eWnhE4yw #DMIS, #aortaed, #mesenteric, #mesentericischemia, #EMC, #UMCG, #NVvV

Haemonetics Commences Full-Market Release of Vascade MVP XL Vascular Closure System

Trial to investigate efficacy of aloe vera in patients with interstitial cystitis #aloevera #cystitis #drghadian https://lnkd.in/dmDwgfwh

Modified pancreaticoduodenectomy: A viable alternative to hepatopancreaticoduodenectomy for middle-third cholangiocarcinoma by Onoe S, Mizuno T (...) Ebata T et 7 al. in HPB (Oxford)

Participate in this #CME activity to discover insights on optimizing the treatment of immunoglobulin A nephropathy and focal segmental glomerulosclerosis: https://ow.ly/KeIu50QGiVm

Decreases in cT1 and liver fat content reflect treatment-induced histological improvements in MASH

Optimizing Treatment and Expanding Indications in Non-Curative Endoscopic Submucosal Dissection by Zhu YN, Yuan XL (...) Ye LS et 4 al. in World J Gastroenterol